Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05394324 · ClinicalTrials.gov registry record
A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products
A clinical trial, sponsored by Johnson & Johnson Surgical Vision.
- Completed
- Registry status
- 1,674
- Enrollment target
NCT05394324: Completed study, sponsored by Johnson & Johnson Surgical Vision.
NCT05394324 is a clinical trial that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 1,674 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05394324 has completed, sponsored by Johnson & Johnson Surgical Vision.
- COMPLETED
- Registry status
- 1,674 participants
- Enrollment target
Study Summary
Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
Primary Outcome
incidence of adverse events that are specified in the ISO 11979-7 Safety and Performance Endpoints.
Interventions
- DEVICE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,674 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2025-05-31 |
What the finished NCT05394324 record still lists
NCT05394324 is an observational study that tracks outcomes without assigning an intervention. Its 1,674 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.
NCT05394324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05394324 about?
NCT05394324 is a clinical study titled "A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products". Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
What is the current status of trial NCT05394324?
This trial is currently completed. The enrollment target is 1,674 participants. The study started on 2022-06-21. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT05394324?
The interventions under investigation include: Intervention (DEVICE).
Who is sponsoring clinical trial NCT05394324?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI